<DOC>
	<DOCNO>NCT00367211</DOCNO>
	<brief_summary>The purpose study evaluate incidence gastric ulcer follow administration either PN 200 Naproxen subject risk develop NSAID-associated ulcer .</brief_summary>
	<brief_title>Study Evaluate Incidence Gastric Ulcers Following Administration Either PN 200 Naproxen Subjects Who Are Risk Developing NSAID-Associated Ulcers .</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Male nonpregnant female subject history osteoarthritis , rheumatoid arthritis , ankylose spondylitis medical condition expect require daily NSAID therapy least 6 month 1849 year age history document , uncomplicated gastric duodenal ulcer ( mucosal break least 3 mm diameter depth , without concurrent bleeding , clot perforation ) within past 5 year OR , 50 year age old ( subject require history document , uncomplicated gastric duodenal ulcer within past 5 year ) . Female subject eligible participation study : 1 . Nonchildbearing potential ( i.e. , physiologically incapable become pregnant ) ; , 2 . Childbearing potential , negative pregnancy test ( urine ) screening , least one follow applies agree subject : Complete abstinence intercourse least 14 day prior first dose study drug , throughout study , 30 day completion study Female sterilization sterilization male partner ; , Hormonal contraception oral route , implant , injectable , vaginal ring ; , Any intrauterine device ( IUD ) publish data show low expected failure rate le 1 % per year ; Double barrier method ( 2 physical barrier 1 physical barrier plus spermicide ) ; Any method publish data show low expected failure rate le 1 % per year . Each subject must able understand comply study procedure require subject able willing provide write informed consent prior study procedure perform . History hypersensitivity omeprazole another protonpump inhibitor . History allergic reaction intolerance NSAID ( include aspirin ) and/or subject history NSAIDinduced symptom asthma , rhinitis , and/or nasal polyp . Participation study investigational treatment 4 week screen . Presence uncontrolled acute chronic medical illness , e.g . gastrointestinal disorder , diabetes , hypertension , thyroid disorder , depression and/or infection would endanger subject participate study . Gastrointestinal disorder surgery lead impaired drug absorption . Evidence uncontrolled , unstable cardio cerebrovascular disorder , investigator 's opinion would endanger subject participate study . Schizophrenia bipolar disorder . Use exclude concomitant medication ( see Section 9.2 ) . A recent history ( past 3 month ) suggestive alcohol drug abuse dependence , include overuse/abuse narcotics management pain . Serious blood coagulation disorder include use systemic anticoagulant . Positive test result H. pylorus screen . Baseline endoscopy show gastric duodenal ulcer least 3 mm diameter depth . Screening laboratory value ALT , AST &gt; 2 time upper limit normal . Estimated creatinine clearance &lt; 30 ml/min . Other note specifically , screen laboratory value clinically significant investigator 's opinion would endanger subject participate study . History malignancy , treat untreated , within past 5 year , exception successfully treat basal cell squamous cell carcinoma skin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Gastric Ulcers</keyword>
	<keyword>NSAID</keyword>
	<keyword>Arthritis</keyword>
</DOC>